You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 268 No. 24, December 23, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Report
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (163)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk of Fatal and Near-Fatal Asthma in Relation to Inhaled Corticosteroid Use

Pierre Ernst, MD; Walter O. Spitzer, MD; Samy Suissa, PhD; Donald Cockcroft, MD; Brian Habbick, MD; Ralph I. Horwitz, MD; Jean-Francois Boivin, MD, PhD; Mary McNutt, MSc; A. Sonia Buist, MD

JAMA. 1992;268(24):3462-3464.


Abstract

Objective.
—To examine the relationship between patterns of use of inhaled beclomethasone dipropionate and the risk of fatal and near-fatal asthma.

Design.
—Nested case-control analysis of a historical cohort; a further analysis.

Setting.
—The 12 301 residents of Saskatchewan aged 5 to 54 years who were dispensed 10 or more asthma drugs from 1978 to 1987.

Patients.
—The 129 persons who experienced asthma death (n=44) and near-death (n=85) and their 655 controls matched as to age and date of entry into the cohort, with the additional matching criteria of at least one hospitalization for asthma in the prior 2 years, region of residence, and having received social assistance.

Main Outcome.
—Life-threatening attacks of asthma defined as death due to asthma or the occurrence of hypercarbia, intubation, and mechanical ventilation during an acute attack of asthma.

Results.
—After accounting for the risk associated with use of other medications and adjustment for markers of risk of adverse events related to asthma, subjects who had been dispensed, on average, one or more metered-dose inhalers of beclomethasone per month over a 1-year period had a significantly lower risk of fatal and near-fatal asthma (odds ratio, 0.1; 95% confidence interval, 0.02 to 0.6). Conclusion.—These data support recent guidelines from several countries that recommend the use of inhaled corticosteroids in moderate and severe asthma.

(JAMA. 1992;268:3462-3464)



Author Affiliations

From the Departments of Epidemiology and Biostatistics (Drs Ernst, Spitzer, Suissa, and Boivin) and Medicine, Montreal General Hospital (Drs Ernst and Suissa), McGill University, Montreal, Quebec; Departments of Medicine (Dr Cockcroft) and Community Health and Epidemiology (Dr Habbick), University of Saskatchewan, Saskatoon; School of Medicine, Yale University, New Haven, Conn (Dr Horwitz); H. E Robertson Laboratory, Laboratory and Disease Control Services Branch, Saskatchewan Health, Regina (Ms McNutt); and Departments of Medicine and Physiology, Oregon Health Sciences University, Portland (Dr Buist).


Footnotes

This study is based, in part, on data provided by the Saskatchewan Department of Health. The interpretations and conclusions contained herein do not necessarily represent those of the Government of Saskatchewan or the Saskatchewan Department of Health.

Reprint requests to Respiratory Epidemiology Unit, 1110 Pine Ave W, Montreal, Quebec, Canada H3A 1A3 (Dr Ernst).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

International Trends in Asthma Mortality Rates in the 5- to 34-Year Age Group: A Call for Closer Surveillance
Wijesinghe et al.
Chest 2009;135:1045-1049.
ABSTRACT | FULL TEXT  

Global strategy for asthma management and prevention: GINA executive summary
Bateman et al.
Eur Respir J 2008;31:143-178.
ABSTRACT | FULL TEXT  

Case-control study of severe life threatening asthma (SLTA) in a developing community
van der Merwe et al.
Thorax 2006;61:756-760.
ABSTRACT | FULL TEXT  

Meta-Analysis: Effect of Long-Acting {beta}-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths
Salpeter et al.
ANN INTERN MED 2006;144:904-912.
ABSTRACT | FULL TEXT  

Regular Use of Corticosteroids and Low Use of Short-Acting {beta}2-Agonists Can Reduce Asthma Hospitalization
Senthilselvan et al.
Chest 2005;127:1242-1251.
ABSTRACT | FULL TEXT  

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture
Suissa et al.
Am. J. Respir. Crit. Care Med. 2004;169:83-88.
ABSTRACT | FULL TEXT  

Profile of Near-Fatal Asthma in an Inner-City Hospital
Dhuper et al.
Chest 2003;124:1880-1884.
ABSTRACT | FULL TEXT  

Lower Physician Estimate of Underlying Asthma Severity Leads to Undertreatment
Wolfenden et al.
Arch Intern Med 2003;163:231-236.
ABSTRACT | FULL TEXT  

Use of anti-inflammatory therapy and asthma mortality in Japan
Suissa and Ernst
Eur Respir J 2003;21:101-104.
ABSTRACT | FULL TEXT  

Asthma in Adventure Travelers: A Prospective Study Evaluating the Occurrence and Risk Factors for Acute Exacerbations
Golan et al.
Arch Intern Med 2002;162:2421-2426.
ABSTRACT | FULL TEXT  

The Effect of Easy Breathing on Asthma Management and Knowledge
Cloutier et al.
Arch Pediatr Adolesc Med 2002;156:1045-1051.
ABSTRACT | FULL TEXT  

Understanding and Use of Inhaler Medication by Asthmatics in Specialty Care in Trinidad* : A Study Following Development of Caribbean Guidelines for Asthma Management and Prevention
Pinto Pereira et al.
Chest 2002;121:1833-1840.
ABSTRACT | FULL TEXT  

Socioeconomic Status, Drug Insurance Benefits, and New Prescriptions for Inhaled Corticosteroids in Schoolchildren With Asthma
Kozyrskyj et al.
Arch Pediatr Adolesc Med 2001;155:1219-1224.
ABSTRACT | FULL TEXT  

Low dose inhaled corticosteroids and the prevention of death from asthma
Kips and Pauwels
Thorax 2001;56:ii74-78.
FULL TEXT  

Race and Sex Differences in Consistency of Care With National Asthma Guidelines in Managed Care Organizations
Krishnan et al.
Arch Intern Med 2001;161:1660-1668.
ABSTRACT | FULL TEXT  

Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics
Sin and Tu
Eur Respir J 2001;17:380-385.
ABSTRACT | FULL TEXT  

Underuse of Inhaled Steroid Therapy in Elderly Patients With Asthma
Sin and Tu
Chest 2001;119:720-725.
ABSTRACT | FULL TEXT  

Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma
Eisner et al.
Eur Respir J 2001;17:233-240.
ABSTRACT | FULL TEXT  

Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack
Kolbe et al.
Thorax 2000;55:1007-1015.
ABSTRACT | FULL TEXT  

Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
Suissa et al.
NEJM 2000;343:332-336.
ABSTRACT | FULL TEXT  

Are Elderly Patients with Obstructive Airway Disease Being Prematurely Discharged?
SIN and TU
Am. J. Respir. Crit. Care Med. 2000;161:1513-1517.
ABSTRACT | FULL TEXT  

Treatment Patterns Among Adult Patients With Asthma: Factors Associated With Overuse of Inhaled {beta}-Agonists and Underuse of Inhaled Corticosteroids
Diette et al.
Arch Intern Med 1999;159:2697-2704.
ABSTRACT | FULL TEXT  

Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma
Guite et al.
Thorax 1999;54:301-307.
ABSTRACT | FULL TEXT  

Societal and health care benefits of early use of inhaled steroids
HAAHTELA and KLAUKKA
Thorax 1998;53:1005-1006.
FULL TEXT  

First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
Blais et al.
Thorax 1998;53:1025-1029.
ABSTRACT | FULL TEXT  

Health Service Use by African Americans and Caucasians with Asthma in a Managed Care Setting
ZORATTI et al.
Am. J. Respir. Crit. Care Med. 1998;158:371-377.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroids and the Prevention of Readmission to Hospital for Asthma
BLAIS et al.
Am. J. Respir. Crit. Care Med. 1998;158:126-132.
ABSTRACT | FULL TEXT  

Risk Factors for Near-fatal Asthma . A Case-Control Study in Hospitalized Patients with Asthma
TURNER et al.
Am. J. Respir. Crit. Care Med. 1998;157:1804-1809.
ABSTRACT | FULL TEXT  

The Red Alert Program for Life-threatening Asthma
Sherman and Capen
Pediatrics 1997;100:187-191.
ABSTRACT | FULL TEXT  

Guidelines and Realities of Asthma Management: The Philadelphia Story
Lang et al.
Arch Intern Med 1997;157:1193-1200.
ABSTRACT  

Epidemiology of Asthma
Letassy
Journal of Pharmacy Practice 1997;10:165-175.
ABSTRACT  

Albuterol in Mild Asthma
Suissa et al.
NEJM 1997;336:729-730.
FULL TEXT  

Beta-Adrenoceptor Agonists Block Corticosteroid Inhibition in Eosinophils
NIELSON and HADJOKAS
Am. J. Respir. Crit. Care Med. 1997;157:184-191.
ABSTRACT | FULL TEXT  

Inhaled Glucocorticoids for Asthma
Barnes
NEJM 1995;332:868-875.
FULL TEXT  

Allergy and Immunology
Smith and deShazo
JAMA 1994;271:1653-1654.
ABSTRACT  

Differences between Inhaled and Oral Glucocorticoid Therapy
Utiger
NEJM 1993;329:1731-1733.
FULL TEXT  

STRONG SUPPORT FOR INHALED STEROIDS IN ASTHMA
JWatch General 1993;1993:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.